Morpholino

MO1-ak2

ID
ZDB-MRPHLNO-090108-2
Name
MO1-ak2
Previous Names
None
Target
Sequence
5' - CATCCAGCTACAAATGAGAAACAGC - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
Splice-blocking MO.
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO1-ak2
Phenotype
Phenotype resulting from MO1-ak2
Phenotype of all Fish created by or utilizing MO1-ak2
Phenotype Fish Conditions Figures
intermediate cell mass of mesoderm apoptotic process increased process quality, abnormal EKW + MO1-ak2 control Fig. 5 from Rissone et al., 2015
hematopoietic stem cell differentiation decreased process quality, abnormal EKW + MO1-ak2 control Fig. 4 from Rissone et al., 2015
blood island apoptotic process increased process quality, abnormal EKW + MO1-ak2 control Fig. 5 from Rissone et al., 2015
hematopoietic progenitor cell differentiation decreased process quality, abnormal EKW + MO1-ak2 control Fig. 4 from Rissone et al., 2015
hematopoietic system apoptotic process increased process quality, abnormal EKW + MO1-ak2 control Fig. 5 from Rissone et al., 2015
granulocyte decreased amount, abnormal EKW + MO1-ak2 control Fig. 3 from Rissone et al., 2015
hematopoietic stem cell differentiation decreased process quality, abnormal EKW + MO1-ak2 + MO2-ak2 control Fig. 4 from Rissone et al., 2015
granulocyte decreased amount, abnormal EKW + MO1-ak2 + MO2-ak2 control Fig. 3 from Rissone et al., 2015
intermediate cell mass of mesoderm apoptotic process increased process quality, abnormal EKW + MO1-ak2 + MO2-ak2 control Fig. 5 from Rissone et al., 2015
blood island apoptotic process increased process quality, abnormal EKW + MO1-ak2 + MO2-ak2 control Fig. 5 from Rissone et al., 2015
hematopoietic progenitor cell differentiation decreased process quality, abnormal EKW + MO1-ak2 + MO2-ak2 control Fig. 4 from Rissone et al., 2015
hematopoietic system apoptotic process increased process quality, abnormal EKW + MO1-ak2 + MO2-ak2 control Fig. 5 from Rissone et al., 2015
leukocyte differentiation disrupted, abnormal WT + MO1-ak2 standard conditions Fig. 3Fig. S4 from Pannicke et al., 2009
hematopoietic stem cell differentiation decreased process quality, abnormal la2Tg + MO1-ak2 control Fig. 4 from Rissone et al., 2015
hematopoietic progenitor cell differentiation decreased process quality, abnormal la2Tg + MO1-ak2 control Fig. 4 from Rissone et al., 2015
hematopoietic stem cell differentiation decreased process quality, abnormal la2Tg + MO1-ak2 + MO2-ak2 control Fig. 4 from Rissone et al., 2015
hematopoietic progenitor cell differentiation decreased process quality, abnormal la2Tg + MO1-ak2 + MO2-ak2 control Fig. 4 from Rissone et al., 2015
Citations